Regulation of the pentose phosphate pathway in cancer

Abstract

Energy metabolism is significantly reprogrammed in many human cancers, and these alterations confer many advantages to cancer cells, including the promotion of biosynthesis, ATP generation, detoxification and support of rapid proliferation. The pentose phosphate pathway (PPP) is a major pathway for glucose catabolism. The PPP directs glucose flux to its oxidative branch and produces a reduced form of nicotinamide adenine dinucleotide phosphate (NADPH), an essential reductant in anabolic processes. It has become clear that the PPP plays a critical role in regulating cancer cell growth by supplying cells with not only ribose-5-phosphate but also NADPH for detoxification of intracellular reactive oxygen species, reductive biosynthesis and ribose biogenesis. Thus, alteration of the PPP contributes directly to cell proliferation, survival and senescence. Furthermore, recent studies have shown that the PPP is regulated oncogenically and/or metabolically by numerous factors, including tumor suppressors, oncoproteins and intracellular metabolites. Dysregulation of PPP flux dramatically impacts cancer growth and survival. Therefore, a better understanding of how the PPP is reprogrammed and the mechanism underlying the balance between glycolysis and PPP flux in cancer will be valuable in developing therapeutic strategies targeting this pathway.

Cited by papers we hold 28

• Energy metabolism in health and diseases · 2025
  No notice
• A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells · 2022
  No notice
• TGF-β signaling in the tumor metabolic microenvironment and targeted therapies · 2022
  No notice
• Effects of Glucose Metabolism, Lipid Metabolism, and Glutamine Metabolism on Tumor Microenvironment and Clinical Implications · 2022
  No notice
• Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment · 2021
  No notice
• Tumor microenvironment and radioresistance · 2021
  No notice
• The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism · 2021
  No notice
• Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation · 2021
  Corrected
• Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine · 2021
  No notice
• TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism · 2020
  No notice
• The Role of Oxidative Stress and Its Counteractive Utility in Colorectal Cancer (CRC) · 2020
  No notice
• NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications · 2020
  No notice
• Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases · 2019
  Not checked
• Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers · 2019
  No notice
• Cancer Metabolism and the Evasion of Apoptotic Cell Death · 2019
  No notice
• Proline Metabolism in Cell Regulation and Cancer Biology: Recent Advances and Hypotheses · 2019
  No notice
• Reprogramming of fatty acid metabolism in cancer · 2019
  No notice
• Identification of a noncanonical function for ribose-5-phosphate isomerase A promotes colorectal cancer formation by stabilizing and activating β-catenin via a novel C-terminal domain. · 2018
  Not checked
• DNA Damage, Repair, and Cancer Metabolism · 2018
  No notice
• Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer · 2018
  No notice

and 8 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.